Acm Research (ACMR) had the highest return between February 22, 2018 and March 8, 2018 by a small-cap US stock, returning 92.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Acm Research (ACMR) | 2/22/2018 - 3/8/2018 | 92.29% |
POET Technologies (POET) | 2/22/2018 - 3/8/2018 | 65.63% |
American Public Education (APEI) | 2/22/2018 - 3/8/2018 | 58.89% |
Transcontinental Realty Investors (TCI) | 2/22/2018 - 3/8/2018 | 56% |
Vicor (VICR) | 2/22/2018 - 3/8/2018 | 38.65% |
Spyre Therapeutics (SYRE) | 2/22/2018 - 3/8/2018 | 38.5% |
Tandem Diabetes Care (TNDM) | 2/22/2018 - 3/8/2018 | 35% |
V2X (VVX) | 2/22/2018 - 3/8/2018 | 33.02% |
Regenxbio (RGNX) | 2/22/2018 - 3/8/2018 | 32.97% |
Zevra Therapeutics (ZVRA) | 2/22/2018 - 3/8/2018 | 31.53% |
Astria Therapeutics (ATXS) | 2/22/2018 - 3/8/2018 | 30.97% |
Cronos (CRON) | 2/22/2018 - 3/8/2018 | 30.15% |
FLEX LNG (FLNG) | 2/22/2018 - 3/8/2018 | 28.57% |
TSS, Inc Common Stock (TSSI) | 2/22/2018 - 3/8/2018 | 28.34% |
Harmonic (HLIT) | 2/22/2018 - 3/8/2018 | 27.12% |
Abeona Therapeutics (ABEO) | 2/22/2018 - 3/8/2018 | 26.36% |
Xencor (XNCR) | 2/22/2018 - 3/8/2018 | 25.83% |
Intellia Therapeutics (NTLA) | 2/22/2018 - 3/8/2018 | 22.79% |
Terawulf (WULF) | 2/22/2018 - 3/8/2018 | 22.37% |
Harrow Health (HROW) | 2/22/2018 - 3/8/2018 | 22.09% |
SurModics (SRDX) | 2/22/2018 - 3/8/2018 | 22.08% |
Precigen (PGEN) | 2/22/2018 - 3/8/2018 | 22.07% |
Barrett Business Services (BBSI) | 2/22/2018 - 3/8/2018 | 22.03% |
Anavex Life Sciences (AVXL) | 2/22/2018 - 3/8/2018 | 21.83% |
Douglas Dynamics (PLOW) | 2/22/2018 - 3/8/2018 | 21.63% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
